http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101816726-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
filingDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101816726-B1 |
titleOfInvention | Controlled-release tablet containing bepotastine |
abstract | The present invention relates to a controlled release tablet containing bepotastine, which is widely used in the treatment of allergic rhinitis, and more particularly, to a multi-layered structure having a rapid release layer and a sustained release layer adjacent to each other, A carboxyvinyl polymer, which is a hydrophilic polymer substance, is contained singly or together with polyethylene oxide, so that it can be taken once a day, and unlike the conventional single sustained release, it is instantaneous due to immediate drug release in the immediate release layer To a controlled-release tablet designed to enable sustained effect development. |
priorityDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.